Blog – Katalyst Wealth

[Stock idea]: NRB Bearings – From a factory fire to a ₹2,500 cr roadmap: NRB Bearings’ Q4

July 30, 2026

NRB Bearings just posted a 77% jump in full-year PAT — but the real story is what happened before this year, not during it. A factory fire, a family settlement, and a demerger all hit this company in the last three years. Q4 FY26 is the quarter management says draws a line under all three. Here’s what stood out, but before that: Spread the Word: If you think our stock recommendations could add value to your friends, relatives, or acquaintances, we’d appreciate you…

[Stock idea]: ₹372 cr → ₹1,000 cr: the 3-year roadmap this ₹2,700 cr company just laid out

July 28, 2026

Sirca Paints India just closed out FY26 with its strongest year yet — but the more interesting story is buried in the concall, not the press release. Revenue crossed ₹492 crore, EBITDA margins expanded even as crude-linked raw material costs spiked, and management just laid out a very specific path to ₹1,000 crore by FY29. Here’s what stood out, but before that: Spread the Word: If you think our stock recommendations could add value to your friends, relatives, or acquaintances, we’d…

[Stock idea]: Windlas Biotech — 13 quarters in a row of record growth

July 23, 2026

While most of the market was distracted by largecap pharma names, a smaller CDMO player quietly delivered its 13th consecutive quarter of record revenue. No new drug launch. No big acquisition. Just consistent execution, disciplined capital allocation, and margins that keep inching up. Here’s what caught our eye, but before that: Help us grow: If you think our stock recommendations could add value to your friends, relatives, or acquaintances, we’d appreciate you spreading the word about Katalyst Wealth. Latest Stock recommendations…

[Stock idea]: GPT Healthcare – This 719-bed hospital chain is scaling to 1,000 beds — here’s the plan

July 21, 2026

GPT Healthcare (ILS Hospitals) just posted its Q4 & FY26 numbers — and on the surface, it looks like a mixed bag. Revenue grew a healthy 24% YoY in Q4, but full-year PAT actually fell 15%. The reason isn’t operational weakness — it’s a single new hospital in Raipur that’s still ramping up. Strip that out, and the mature network is running at a 23%+ EBITDA margin. Here are my notes from the results, but before that: Help us grow: If…